BIND Therapeutics To Report First Quarter 2014 Financial Results On May 8, 2014
Published: May 01, 2014
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced it will report first quarter 2014 financial results on Thursday, May 8, 2014. BIND’s management team will host a conference call and audio webcast at 8:30 a.m., Eastern Time on Thursday, May 8, 2014 to discuss the quarterly results and recent business developments.
Help employers find you! Check out all the jobs and post your resume.